Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NNZ-2566: Phase Ib data

Neuren Pharmaceuticals Ltd. (ASX:NEU), Auckland, New Zealand
Product: NNZ-2566
Business: Inflammation
Molecular target:

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE